Testing effectiveness (Phase 2)Study completedNCT00719264
What this trial is testing
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
Who this might be right for
CarcinomaAdenocarcinomaRenal Cell+2 more
Novartis Pharmaceuticals 365